A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 21, 2009

Frequent False-Positive Drug Tests With Efavirenz Users

Ninety-eight percent of people with HIV on a regimen containing efavirenz (found in Sustiva and Atripla) tested false positive for benzodiazepines—prescription sedatives—on a widely used drug test, according to study results published online in Clinical Infectious Diseases. These data suggest that clinicians and others who order routine testing for illicit drug use need to use extra caution when interpreting the results involving people using efavirenz.

Researchers have previously reported that random urine drug testing of people taking efavirenz sometimes results in a false-positive result for marijuana use. Though a more specific test for the active ingredient in marijuana can reveal that people aren’t actually using the drug, this has sometimes led to complications for people who must be tested for illicit drug use, such as for their jobs or as a requirement of their parole. Until now, however, there have been no studies showing that efavirenz could result in a false-positive result for benzodiazepines—including drugs such as Valium (diazepam) and Ativan (lorazepam), which are commonly abused by people with substance-use disorders.

Antje Blank, MD, from the University Hospital Heidelberg in Germany, and his colleagues decided to study the problem after several of their patients tested positive for benzodiazepines on the commonly used Triage 8 drug screen, but were not taking the drugs. All were on a regimen containing efavirenz. They enrolled 100 HIV-positive patients, half of whom were on an efavirenz regimen and half who were not. All of the patients were screened using several of the most widely used urine drug tests, including the Triage 8, the Drug Screen Multi 5 and the Drug Control 008A444.

Blank’s team found efavirenz resulted in a false positive for benzodiazepines 98 percent of the time. All 50 of the people on an efavirenz regimen tested positive for benzodiazepines on the Triage 8 test, compared with only one of the people on a non-efavirenz regimen. Forty-six of the people taking efavirenz also tested positive for benzodiazepines on the Drug Screen Multi 5 test. Subsequent screenings with a more sensitive test revealed that only one of the 50 was actually taking benzodiazepines. The team found no false positives for marijuana.

“Because efavirenz is an antiretroviral drug that is often given to HIV-infected patients,” the authors conclude, “it is therefore of utmost importance that clinicians and patients know about this cross-reactivity to avoid incorrect consequences after false-positive urine drug screening test results.”

Search: Efavirenz, Sustiva, Atripla, Benzodiazepene, Valium, diltiazem, Atavan, drug test, urinalysis, urine, marijuana, illicit drug


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Skyline, San Francisco, 2011-07-31 19:39:13
Im traveling over seas to have a new job and now im completely scared about the possibility to have a false positive in drug tests for ilicit drugs - I want to know how often i can have a false positive cause Im taking efavirenz - I dont want to disclose what medicines im taking couse the lab probably will mention that to my employer and is the same to disclose that I have HIV but if I dont mention that how possible is to have a false positive result. Im so angry becouse it is so unfair.

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    complexlogic
    New York City
    New York


    justin1o
    chicago
    Illinois


    Antonio
    Garden Grove
    California


    Milwvirgo
    Milwaukee
    Wisconsin
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.